Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Google vs. Samsung: The Ultimate Biotech Showdown

"Our mandate is to become No. 1 in everything we enter into, so  our long-term goal is to become a leading pharmaceutical company in the world."

That's what Christopher Hansung Ko, CEO of Samsung's (NASDAQOTH: SSNLF  ) Bioepis unit, had to say about his company's unexpected dive into biotech.

Of course, to become that dominant, Samsung would have to beat a lot of other pharma companies -- and face off against Google  (NASDAQ: GOOGL  ) (NASDAQ: GOOG  ) , whose investments in Calico to combat aging also have transformative possibilities.

The Korean conglomerate is looking to compete in biosimilars, or the generic versions of biologic drugs, and it's paired up with a number of health care heavyweights (including Biogen) to make that happen. It's a pretty target-rich environment, and a market that may be worth as much as $24 billion by 2019. Samsung isn't idly grabbing headlines either -- it's investing $2 billion to get this foray started, with the expectation of selling $1.8 billion a year in biopharmaceutical products by 2020.

In the following video, from Market Checkup, the Motley Fool's health care-focused investing show, Motley Fool health care analysts Michael Douglass and David Williamson dig into the details and look at the investing takeaways in this surprising and exciting story.

Can Google and Samsung keep up with this incredible stock?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2961485, ~/Articles/ArticleHandler.aspx, 8/31/2015 6:04:12 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Michael Douglass

As the Motley Fool's Health Care Editor/Analyst, I focus on all things health care -- although my greatest interest is in the megatrends reshaping the American health care system, including the Affordable Care Act, Accountable Care Organizations, a shifting regulatory landscape, and the new drug discoveries fundamentally changing disease management and treatment.

Today's Market

updated Moments ago Sponsored by:
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASD 4,776.51 -51.82 -1.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 3:59 PM
GOOG $618.25 Down -12.13 -1.92%
Google (C shares) CAPS Rating: ****
GOOGL $647.82 Down -11.87 -1.80%
Google (A shares) CAPS Rating: ****
SSNLF $875.00 Up +25.00 +0.00%
Samsung CAPS Rating: ***